Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value: $2.563B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GHRS | GH RESEARCH PLC | 9,275,158 | $205M | 8.0% | — | — | ORDINARY SHARES | G3855L106 |
| KYMR | KYMERA THERAPEUTICS INC | 3,180,658 | $187M | 7.3% | — | — | COM | 501575104 |
| OLMA | OLEMA PHARMACEUTICALS INC | 6,661,503 | $184M | 7.2% | — | — | COM | 68062P106 |
| RCUS | ARCUS BIOSCIENCES INC | 3,229,822 | $113M | 4.4% | — | — | COM | 03969F109 |
| — | MERUS N V | 5,060,071 | $111M | 4.3% | — | — | CALL | N5749R900 |
| ARGX | ARGENX SE | 366,204 | $111M | 4.3% | — | — | SPONSORED ADR | 04016X101 |
| — | REPARE THERAPEUTICS INC | 3,722,398 | $97.68M | 3.8% | — | — | COM | 760273102 |
| XOMA | XOMA CORP DEL | 3,530,543 | $87.38M | 3.4% | — | — | COM NEW | 98419J206 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,901,759 | $69.14M | 2.7% | — | — | COM | 74366E102 |
| LXRX | LEXICON PHARMACEUTICALS INC | 14,360,000 | $69.07M | 2.7% | — | — | COM NEW | 528872302 |
| RVMD | REVOLUTION MEDICINES INC | 2,485,049 | $68.36M | 2.7% | — | — | COM | 76155X100 |
| RLAY | RELAY THERAPEUTICS INC | 2,049,113 | $64.61M | 2.5% | — | — | COM | 75943R102 |
| GLPG | GALAPAGOS NV | 1,119,733 | $58.91M | 2.3% | — | — | SPON ADR | 36315X101 |
| — | AMARIN CORP PLC | 11,407,182 | $58.18M | 2.3% | — | — | SPONS ADR NEW | 023111206 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,005,862 | $54.1M | 2.1% | — | — | COM | 35104E100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,486,429 | $47.52M | 1.9% | — | — | COM | 87164F105 |
| ACIU | AC IMMUNE SA | 6,935,179 | $46.53M | 1.8% | — | — | SHS | H00263105 |
| — | VERASTEM INC | 14,977,258 | $46.13M | 1.8% | — | — | COM | 92337C104 |
| — | RAIN THERAPEUTICS INC | 2,957,807 | $44.25M | 1.7% | — | — | COM | 75082Q105 |
| WHWK | AADI BIOSCIENCES INC | 1,147,052 | $33.69M | 1.3% | — | — | COM | 00032Q104 |
| SPRO | SPERO THERAPEUTICS INC | 1,809,352 | $33.31M | 1.3% | — | — | COM | 84833T103 |
| KURA | KURA ONCOLOGY INC | 1,635,112 | $30.63M | 1.2% | — | — | COM | 50127T109 |
| TYRA | TYRA BIOSCIENCES INC | 1,694,933 | $29.81M | 1.2% | — | — | COM | 90240B106 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 8,383,645 | $28.67M | 1.1% | — | — | COM | 45665G303 |
| — | PIERIS PHARMACEUTICALS INC | 5,328,239 | $27.55M | 1.1% | — | — | COM | 720795103 |
| REPL | REPLIMUNE GROUP INC | 926,529 | $27.46M | 1.1% | — | — | COM | 76029N106 |
| — | CTI BIOPHARMA CORP | 8,929,690 | $26.34M | 1.0% | — | — | COM | 12648L601 |
| — | VIRACTA THERAPEUTICS INC | 3,094,174 | $24.82M | 1.0% | — | — | COM | 92765F108 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,373,044 | $24.71M | 1.0% | — | — | COM | 00461U105 |
| XENE | XENON PHARMACEUTICALS INC | 1,571,778 | $24.02M | 0.9% | — | — | COM | 98420N105 |
| — | IKENA ONCOLOGY INC | 1,832,071 | $23.12M | 0.9% | — | — | COM | 45175G108 |
| — | ESSA PHARMA INC | 2,851,461 | $22.81M | 0.9% | — | — | COM NEW | 29668H708 |
| OVID | OVID THERAPEUTICS INC | 6,631,051 | $22.28M | 0.9% | — | — | COM | 690469101 |
| JANX | JANUX THERAPEUTICS INC | 1,017,314 | $22M | 0.9% | — | — | COM | 47103J105 |
| — | POINT BIOPHARMA GLOBAL INC | 2,772,226 | $21.32M | 0.8% | — | — | COM | 730541109 |
| — | GLYCOMIMETICS INC | 9,544,262 | $20.9M | 0.8% | — | — | COM | 38000Q102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 953,879 | $20.08M | 0.8% | — | — | COM | 22663K107 |
| — | NGM BIOPHARMACEUTICALS INC | 955,000 | $20.07M | 0.8% | — | — | COM | 62921N105 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 810,284 | $19.23M | 0.8% | — | — | COM | 23954D109 |
| — | MOLECULAR TEMPLATES INC | 2,856,599 | $19.17M | 0.7% | — | — | COM | 608550109 |
| — | ALPINE IMMUNE SCIENCES INC | 1,589,495 | $16.96M | 0.7% | — | — | COM | 02083G100 |
| CGEM | CULLINAN ONCOLOGY INC | 735,106 | $16.59M | 0.6% | — | — | COM | 230031106 |
| — | GRITSTONE BIO INC | 1,528,072 | $16.5M | 0.6% | — | — | COM | 39868T105 |
| — | CALITHERA BIOSCIENCES INC | 7,452,331 | $16.25M | 0.6% | — | — | COM | 13089P101 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $16.21M | 0.6% | — | — | SPONSERED ADS | 13124Q106 |
| — | CONTRAFECT CORP | 3,972,300 | $16.09M | 0.6% | — | — | COM NEW | 212326300 |
| — | SUTRO BIOPHARMA INC | 826,825 | $15.62M | 0.6% | — | — | COM | 869367102 |
| SLN | SILENCE THERAPEUTICS PLC | 666,666 | $14.41M | 0.6% | — | — | ADS | 82686Q101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 804,126 | $13.23M | 0.5% | — | — | COM | 92790C104 |
| COGT | COGENT BIOSCIENCES | 1,532,282 | $12.89M | 0.5% | — | — | COM | 19240Q201 |
| — | ELEVATION ONCOLOGY INC | 1,590,298 | $12.39M | 0.5% | — | — | COM | 28623U101 |
| — | CIDARA THERAPEUTICS INC | 4,776,904 | $10.7M | 0.4% | — | — | COM | 171757107 |
| — | ANGION BIOMEDICA CORP | 1,071,297 | $10.47M | 0.4% | — | — | COM | 03476J107 |
| NUVL | NUVALENT INC | 448,512 | $10.11M | 0.4% | — | — | COM | 670703107 |
| — | MEI PHARMA INC | 3,532,057 | $9.748M | 0.4% | — | — | COM NEW | 55279B202 |
| ANAB | ANAPTYSBIO INC | 334,398 | $9.069M | 0.4% | — | — | COM | 032724106 |
| MIRM | MIRUM PHARMACEUTICALS INC | 435,936 | $8.684M | 0.3% | — | — | COM | 604749101 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,363,435 | $8.426M | 0.3% | — | — | COM | 28617K101 |
| MOLN | MOLECULAR PARTNERS AG | 419,008 | $8.267M | 0.3% | — | — | ADS | 60853G106 |
| IVA | INVENTIVA SA | 544,500 | $7.705M | 0.3% | — | — | ADS | 46124U107 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 4,012,404 | $7.704M | 0.3% | — | — | COM NEW | 372427401 |
| — | ERYTECH PHARMA | 1,314,656 | $7.586M | 0.3% | — | — | SPONSORED ADR | 29604W108 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,370,947 | $6.635M | 0.3% | — | — | COM | 221015100 |
| — | AILERON THERAPEUTICS INC | 5,265,555 | $5.371M | 0.2% | — | — | COM | 00887A105 |
| — | GALMED PHARMACEUTICALS LTD | 1,799,694 | $5.021M | 0.2% | — | — | SHS | M47238106 |
| — | EUCRATES BIOMEDICAL ACQU COR | 500,000 | $4.955M | 0.2% | — | — | UNIT 10/23/2027 | G3141W114 |
| — | FRAZIER LIFESCIENCES ACQU CO | 500,000 | $4.93M | 0.2% | — | — | UNIT 12/09/2025 | G3710A121 |
| — | 5 01 ACQUISITION CORP | 500,000 | $4.9M | 0.2% | — | — | COM CL A | 33836P105 |
| — | RESEARCH ALLIANCE CORP II | 500,000 | $4.83M | 0.2% | — | — | COM CL A | 760873109 |
| — | X4 PHARMACEUTICALS INC | 847,879 | $4.485M | 0.2% | — | — | COM | 98420X103 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 289,663 | $4.304M | 0.2% | — | — | COM | 00509G209 |
| — | FORWARD PHARMA A/S | 432,892 | $2.987M | 0.1% | — | — | SPONSORD ADS NEW | 34986J204 |
| — | JIYA ACQUISITION CORP | 300,000 | $2.934M | 0.1% | — | — | COM CL A | 47760M102 |
| RZLT | REZOLUTE INC | 190,815 | $1.416M | 0.1% | — | — | COM NEW | 76200L309 |
| — | SELECTA BIOSCIENCES INC | 319,678 | $1.33M | 0.1% | — | — | COM | 816212104 |